title: Predicting antiarrhythmic drug efficacy.
abstract: For years, electrophysiologic testing was regarded as the best way to select effective pharmacologic therapy. But now it appears that Holter monitoring is just as accurate--as well as simpler, safer, and cheaper. Nevertheless, most patients eventually will need an electrophysiologic study because of the high rate of arrhythmia recurrence.
authors.affiliation: Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City.
authors.forename: J W
authors.initials: JW
authors.lastname: Mason
mesh_terms: D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D015716:Electrocardiography, Ambulatory; D004594:Electrophysiology; D006801:Humans; D015337:Multicenter Studies as Topic; D011237:Predictive Value of Tests; D016032:Randomized Controlled Trials as Topic; D012008:Recurrence; D017180:Tachycardia, Ventricular / Q000188:drug therapy* / Q000503:physiopathology / Q000628:therapy
chemical_list: D000889:Anti-Arrhythmia Agents